EDGAR Filing Documents for 0001062993-16-008235

Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:

SEC Accession No. 0001062993-16-008235

Filing Date

2016-03-09

Accepted

2016-03-09 17:22:01

Documents

Period of Report

2015-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 40-F	form40f.htm	40-F	29989
2	EXHIBIT 99.1	exhibit99-1.htm	EX-99.1	281456
3	EXHIBIT 99.2	exhibit99-2.htm	EX-99.2	273188
4	EXHIBIT 99.3	exhibit99-3.htm	EX-99.3	410406
5	EXHIBIT 99.4	exhibit99-4.htm	EX-99.4	6195
6	EXHIBIT 99.5	exhibit99-5.htm	EX-99.5	6234
7	EXHIBIT 99.6	exhibit99-6.htm	EX-99.6	2271
8	EXHIBIT 99.7	exhibit99-7.htm	EX-99.7	2184
9	EXHIBIT 99.8	exhibit99-8.htm	EX-99.8	1741
10	GRAPHIC	exhibit99-1x1x1.jpg	GRAPHIC	6292
11	GRAPHIC	exhibit99-2x1x1.jpg	GRAPHIC	6552
12	GRAPHIC	exhibit99-2x6x1.jpg	GRAPHIC	20492
13	GRAPHIC	exhibit99-2x7x1.jpg	GRAPHIC	22169
14	GRAPHIC	exhibit99-2x8x1.jpg	GRAPHIC	10020
15	GRAPHIC	financialsx1x1.jpg	GRAPHIC	6269
16	GRAPHIC	exhibit99-1x7x1.jpg	GRAPHIC	20477
17	GRAPHIC	exhibit99-1x8x1.jpg	GRAPHIC	23016
18	GRAPHIC	exhibit99-1x9x1.jpg	GRAPHIC	9906
	Complete submission text file	0001062993-16-008235.txt		1188366

Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9

Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627

Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)